BioBreakthroughs

Join us on the latest episode! Our Guest: Michael Oleksiw, CEO at Pleio.

What you'll get out of this episode:
  • Human + AI Synergy: Pleio combines emotionally aware AI with peer-to-patient support to boost medication adherence.
  • Overcoming Emotional Barriers: Emotions like fear, loneliness, and stigma are major challenges after diagnosis.
  • Real-World Impact: Pleio's approach improved adherence rates by up to 28% in GLP-1 medication trials.
  • Ethical AI in Healthcare: Patient data is de-identified and overseen by a medical board to ensure ethical use.
  • Laser Focus on Loneliness: Pleio’s next frontier is tackling loneliness as a primary emotional barrier in healthcare.


To Learn More About Our Guest And Their Company:
Guest LinkedIn https://www.linkedin.com/in/michaeloleksiw/
Company LinkedIn https://www.linkedin.com/company/pleio-inc/
Website http://www.pleio.com

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

What is BioBreakthroughs?

Welcome to BioBreakthroughs, the podcast that delves deep into the world of biotech and pharmaceuticals to bring you the latest and most exciting advancements in the field. Join us as we explore groundbreaking discoveries, cutting-edge research, and game-changing innovations that are shaping the future of healthcare. Produced by Slice of Healthcare.